Amgen CEO discusses challenges, opportunities of biotechnology
As chairman and chief executive officer of Amgen, Robert A. Bradway is keenly aware of how tough and how expensive it is to bring new drugs to market.
He also knows pharmaceutical companies must strike a delicate balance between pleasing shareholders … Read More »